Santen Pharmaceutical Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SNPHF research report →
About the company
Santen Pharmaceutical Co. , Ltd. is a global enterprise specializing in the research, development, manufacturing, and commercialization of pharmaceuticals and medical devices.
- CEO
- Takeshi Ito
- IPO
- 2010
- Employees
- 3,744
- HQ
- Osaka, JP
Price Chart
- Market Cap
- $4.20B
- P/E
- 19.22
- P/S
- 2.44
- P/B
- 2.42
- EV/EBITDA
- 9.29
- Div Yield
- 1.72%
- Gross Margin
- 55.20%
- Op Margin
- 15.50%
- Net Margin
- 12.81%
- ROE
- 13.15%
- ROIC
- 10.68%
- Revenue
- $293.46B · -2.18%
- Net Income
- $37.60B · 3.72%
- EPS
- $115.04 · 10.64%
- Op Income
- $45.50B
- FCF YoY
- -32.03%
- 52W High
- $13.06
- 52W Low
- $8.88
- 50D MA
- $11.23
- 200D MA
- $10.45
- Beta
- 0.25
- Avg Volume
- 16
Get TickerSpark's AI analysis on SNPHF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our SNPHF coverage
Recent articles, reports, and earnings notes.
No research on SNPHF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate SNPHF report →Similar companies
Peers in the same neighborhood.